EP 1496912 A1 20050119 - COMBINATION OF BRIMONIDINE AND TIMOLOL FOR TOPICAL OPHTHALMIC USE
Title (en)
COMBINATION OF BRIMONIDINE AND TIMOLOL FOR TOPICAL OPHTHALMIC USE
Title (de)
KOMBINATION VON BRIMONIDIN UND TIMOLOL ZUR LOKALEN OPHTHALMISCHEN ANWENDUNG
Title (fr)
ASSOCIATION DE BRIMONIDINE ET DE TIMOLOL POUR UTILISATION OPHTALMOLOGIQUE TOPIQUE
Publication
Application
Priority
- US 0310885 W 20030409
- US 12679002 A 20020419
Abstract (en)
[origin: US2021405280A1] Disclosed are pharmaceutical compositions comprising brimonidine and timolol for topical ophthalmic delivery and a method of treatment comprising administering said composition when indicated for glaucoma and associated conditions such as elevated intraocular pressure in the eyes of humans.
IPC 1-7
IPC 8 full level
A61K 31/498 (2006.01); A61K 31/535 (2006.01); A61K 31/5377 (2006.01); A61K 45/06 (2006.01); A61K 47/18 (2006.01); A61P 27/02 (2006.01); A61P 27/06 (2006.01)
CPC (source: EP KR US)
A61K 9/0048 (2013.01 - EP US); A61K 9/08 (2013.01 - US); A61K 31/4168 (2013.01 - EP US); A61K 31/498 (2013.01 - EP KR US); A61K 31/535 (2013.01 - EP US); A61K 31/5377 (2013.01 - EP KR US); A61K 45/06 (2013.01 - EP US); A61K 47/02 (2013.01 - EP US); A61P 27/00 (2017.12 - EP); A61P 27/04 (2017.12 - EP); F21V 23/002 (2013.01 - US); F21V 23/004 (2013.01 - US); F21V 23/023 (2013.01 - US); G02B 6/0073 (2013.01 - US); A61P 27/02 (2017.12 - EP US); A61P 27/06 (2017.12 - EP US)
Citation (search report)
See references of WO 03088973A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
US 2021405280 A1 20211230; AU 2003228480 A1 20031103; AU 2003228480 B2 20060727; BR 0302584 A 20040309; CA 2440764 A1 20031019; CA 2440764 C 20051025; CN 100558364 C 20091111; CN 101664414 A 20100310; CN 1516588 A 20040728; CY 1114048 T1 20160727; DK 1496912 T3 20130402; EP 1496912 A1 20050119; EP 1496912 B1 20130109; EP 1496912 B9 20150617; EP 2241319 A1 20101020; ES 2399045 T3 20130325; HK 1067549 A1 20050603; JP 2005523316 A 20050804; KR 100723189 B1 20070529; KR 20040100844 A 20041202; MX 368377 B 20190930; MX PA03008401 A 20040316; NO 20044450 L 20041109; NO 326579 B1 20090112; NZ 528945 A 20060428; PT 1496912 E 20130213; SI 1496912 T1 20130329; TW 200402296 A 20040216; TW I351959 B 20111111; US 2003199507 A1 20031023; US 2003199509 A1 20031023; US 2004102445 A1 20040527; US 2008132512 A1 20080605; US 2012184551 A1 20120719; US 2013116255 A1 20130509; US 2013196995 A1 20130801; US 2013324534 A1 20131205; US 2015087647 A1 20150326; US 2016303119 A1 20161020; US 2017157138 A1 20170608; US 2018042932 A1 20180215; US 2018064720 A1 20180308; US 2018064721 A1 20180308; US 2020129520 A1 20200430; US 7030149 B2 20060418; US 7320976 B2 20080122; US 7323463 B2 20080129; US 8133890 B2 20120313; US 8354409 B2 20130115; US 8748425 B2 20140610; US 9474751 B1 20161025; US 9770453 B2 20170926; US 9907801 B1 20180306; US 9907802 B1 20180306; WO 03088973 A1 20031030
DOCDB simple family (application)
US 202117168513 A 20210205; AU 2003228480 A 20030409; BR 0302584 A 20030409; CA 2440764 A 20030409; CN 03800468 A 20030409; CN 200910174400 A 20030409; CY 131100193 T 20130301; DK 03726234 T 20030409; EP 03726234 A 20030409; EP 10171064 A 20030409; ES 03726234 T 20030409; HK 05100007 A 20050103; JP 2003585725 A 20030409; KR 20037015881 A 20031204; MX 2014003586 A 20030409; MX PA03008401 A 20030409; NO 20044450 A 20041019; NZ 52894503 A 20030409; PT 03726234 T 20030409; SI 200332241 T 20030409; TW 92109050 A 20030418; US 0310885 W 20030409; US 12679002 A 20020419; US 201113308507 A 20111130; US 201213727106 A 20121226; US 201313801252 A 20130313; US 201313957287 A 20130801; US 201414263740 A 20140428; US 201615192729 A 20160624; US 201715439112 A 20170222; US 201715667248 A 20170802; US 201715802179 A 20171102; US 201715802229 A 20171102; US 201916405813 A 20190507; US 35762203 A 20030203; US 68594103 A 20031014; US 94682807 A 20071128